首页> 中文期刊> 《生物医学研究杂志(英文版)》 >(+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines

(+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines

         

摘要

Stroke is one of the leading causes of disability and death globally.It occurs when a major artery is occluded in thebrain and leads to death of cells within the injured tissue.(+)-Bomeol,a simple bicyclic monoterpene extracted from traditional Chinese medicine,is widely used in various types of diseases.However,no study has proved the effects of (+)-borneol on functional recovery from permanent ischemic stroke and the mechanism is still unknown.Here,we report that in the rat model of permanent cerebral ischemia,we found that (+)-borneol (1.0 mg/kg) significantly ameliorated infarct size and neurological scores via reducing the expression of inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-α) in a dose dependent manner.Notably,(+)-bomeol showed long-term effects on the improvement of sensorimotor functions in the photothrombotic model of stroke,which decreased the number of foot faults in the grid-walking task and forelimb asymmetry scores in the cylinder task,at least in part through reducing loss of dendritic spines in the length,brunch number and density.These findings suggest that (+)-borneol could serve as a therapeutic target for ischemic stroke.

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2017年第4期|306-314|共9页
  • 作者单位

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Institution of Stem Cells and Neuroregeneration,School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    Department of Pharmacology, School of Pharmacy, Nanjing Medical University, Nanjing, Jiangsu 211166, China;

    The Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing, Jiangsu 211166, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理生理学;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号